National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Fluocinolone acetonide intravitreal implant (Iluvien®) for non-infectious uveitis. HTA ID: 20050

Fluocinolone acetonide intravitreal implant (Iluvien®) is indicated for the prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye.

 

NCPE Assessment Process Complete
Rapid review commissioned 23/11/2020
Rapid review completed 21/12/2020
Rapid Review outcome A full HTA is not recommended. The NCPE recommends that fluocinolone acetonide intravitreal implant not be considered for reimbursement at the submitted price*.

 

*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.